 |
3P BIOPHARMACEUTICALS |
CRO / CMO |
Strain development and RCB manufacturing in microbial expression systems (Bacteria and yeast) |
5RTM |
Strain development and RCB manufacturing in microbial expression systems (Bacteria and yeast)
Type:
CRO / CMO
|
|
3P BIOPHARMACEUTICALS |
CRO / CMO |
Stability studies services |
5RTM |
Stability studies services
Type:
CRO / CMO
|
|
3P BIOPHARMACEUTICALS |
CRO / CMO |
Mammalian cell line development |
5RTM |
Mammalian cell line development
Type:
CRO / CMO
|
|
3P BIOPHARMACEUTICALS |
CRO / CMO |
GMP Cell Bank Manufacturing (MCB, WCB) and storage |
5RTM |
GMP Cell Bank Manufacturing (MCB, WCB) and storage
Type:
CRO / CMO
|
|
3P BIOPHARMACEUTICALS |
CRO / CMO |
Analytical methods development, qualification and validation platform for NBE and Biosimilars |
5RTM |
Analytical methods development, qualification and validation platform for NBE and Biosimilars
Type:
CRO / CMO
|
|
3P BIOPHARMACEUTICALS |
CRO / CMO |
Process development, optimization and formulation development |
5RTM |
Process development, optimization and formulation development
Type:
CRO / CMO
|
|
3P BIOPHARMACEUTICALS |
CRO / CMO |
Technology transfer, Scale-up and non-GMP manufacturing services |
5RTM |
Technology transfer, Scale-up and non-GMP manufacturing services
Type:
CRO / CMO
|
|
3P BIOPHARMACEUTICALS |
CRO / CMO |
GMP manufacturing mammalian services (up to 2000L) |
5RTM |
GMP manufacturing mammalian services (up to 2000L)
Type:
CRO / CMO
|
|
3P BIOPHARMACEUTICALS |
CRO / CMO |
Cell therapy services |
5RTM |
Cell therapy services
Type:
CRO / CMO
|
|
3P BIOPHARMACEUTICALS |
CRO / CMO |
GMP manufacturing microbial services (up to 1000L) |
5RTM |
GMP manufacturing microbial services (up to 1000L)
Type:
CRO / CMO
|
|
3P BIOPHARMACEUTICALS |
CRO / CMO |
GMP manufacturing services for Clinical Trials and Commercial |
5RTM |
GMP manufacturing services for Clinical Trials and Commercial
Type:
CRO / CMO
|
|
3P BIOPHARMACEUTICALS |
CRO / CMO |
DS & DP Testing and release |
5RTM |
DS & DP Testing and release
Type:
CRO / CMO
|
|
3P BIOPHARMACEUTICALS |
CRO / CMO |
Comparability studies services |
5RTM |
Comparability studies services
Type:
CRO / CMO
|
 |
53Biologics |
CRO / CMO |
Process development (USP & DSP): optimization of the production process and purification phases. The company goal is to get all bioprocess stages established, optimized, characterized and ready to be transferred for manufacturing. |
2PreV |
Process development (USP & DSP): optimization of the production process and purification phases. The company goal is to get all bioprocess stages established, optimized, characterized and ready to be transferred for manufacturing.
Type:
CRO / CMO
|
|
53Biologics |
CRO / CMO |
Analytics: implement, develop and qualify the analytical methods needed for the characterization of the protein of interest. The company has a broad range of techniques available for the physic-chemical characterization of recombinant proteins |
3CV |
Analytics: implement, develop and qualify the analytical methods needed for the characterization of the protein of interest. The company has a broad range of techniques available for the physic-chemical characterization of recombinant proteins
Type:
CRO / CMO
|
|
53Biologics |
CRO / CMO |
Contract Productions: offers a manufacturing structure fully customizable and adaptable to fulfill its clients need in time, cost and manner in the production capacity for your recombinant protein. |
3CV |
Contract Productions: offers a manufacturing structure fully customizable and adaptable to fulfill its clients need in time, cost and manner in the production capacity for your recombinant protein.
Type:
CRO / CMO
|
|
53Biologics |
CRO / CMO |
Cell line transformation, banking and characterization (cGMP if required): producing recombinant proteins (monoclonal, fusion, chimeric and fragment antibodies, biosimilars, enzymes, anticoagulants, vaccines..) in a wide range of microbial expression sys |
3CV |
Cell line transformation, banking and characterization (cGMP if required): producing recombinant proteins (monoclonal, fusion, chimeric and fragment antibodies, biosimilars, enzymes, anticoagulants, vaccines..) in a wide range of microbial expression sys
Type:
CRO / CMO
|
 |
ADL Bionatur Solutions |
CRO / CMO
Screening |
Biobide's platfom for Toxicity and Efficacy Assays of active compounds in Zebra Fish (validated and included in international regulations). Long track record of services to pharmas, agro-food, and cosmetic companies. |
5RTM |
Biobide's platfom for Toxicity and Efficacy Assays of active compounds in Zebra Fish (validated and included in international regulations). Long track record of services to pharmas, agro-food, and cosmetic companies.
Type:
CRO / CMO
Screening
|
|
ADL Bionatur Solutions |
Drug Delivery
Enabling Technologies |
VACC-ZERA platform for improvement of the immune response raised by recombinant vaccines (proteins or DNA/RNA vaccines). Elimination of cold-chain for storage by formation of metastable nanostructures comprising the antigen before delivery. |
3CV |
VACC-ZERA platform for improvement of the immune response raised by recombinant vaccines (proteins or DNA/RNA vaccines). Elimination of cold-chain for storage by formation of metastable nanostructures comprising the antigen before delivery.
Type:
Drug Delivery
Enabling Technologies
|
|
ADL Bionatur Solutions |
CRO / CMO
Enabling Technologies |
CLICK-GENE. SPLITTERA platform for gene therapy and gene editing. Overcomes gene size limitations of viral vectors by in-vivo covalent reconstitution of large proteins mediated by split inteins. |
2PreV |
CLICK-GENE. SPLITTERA platform for gene therapy and gene editing. Overcomes gene size limitations of viral vectors by in-vivo covalent reconstitution of large proteins mediated by split inteins.
Type:
CRO / CMO
Enabling Technologies
|
|
ADL Bionatur Solutions |
CRO / CMO
Enabling Technologies
Screening |
CLICK-BIO. SPLITTERA Split-intein site-specific protein conjugation platform. Allows functionalization of any Ab format or protein. Capacity to obtain tailor-made antibodies libraries with unique features. |
5RTM |
CLICK-BIO. SPLITTERA Split-intein site-specific protein conjugation platform. Allows functionalization of any Ab format or protein. Capacity to obtain tailor-made antibodies libraries with unique features.
Type:
CRO / CMO
Enabling Technologies
Screening
|
|
ADL Bionatur Solutions |
Drug Delivery
Enabling Technologies |
CLICK-VLP. Split Intein-mediated ANTIGEN DISPLAY for VLPs surface functionalization. It’s a “glue“ for functioning VLPs, overcoming limitations in production of classical VLPs. |
3CV |
CLICK-VLP. Split Intein-mediated ANTIGEN DISPLAY for VLPs surface functionalization. It’s a “glue“ for functioning VLPs, overcoming limitations in production of classical VLPs.
Type:
Drug Delivery
Enabling Technologies
|
|
ADL Bionatur Solutions |
CRO / CMO
Drug Delivery
Enabling Technologies |
CLICK-TARGET. SPLITTERA technology for gene therapy. Allows the decoration of viral particles with covalently bound effectors making possible to target viral particles to specific tissues. |
2PreV |
CLICK-TARGET. SPLITTERA technology for gene therapy. Allows the decoration of viral particles with covalently bound effectors making possible to target viral particles to specific tissues.
Type:
CRO / CMO
Drug Delivery
Enabling Technologies
|
 |
ADM BIOPOLIS |
CRO / CMO |
Contract manufacturing: upstream and downstream development, analytical development, scale-up |
5RTM |
Contract manufacturing: upstream and downstream development, analytical development, scale-up
Type:
CRO / CMO
|
|
ADM BIOPOLIS |
CRO / CMO |
Metagenomics and metabolomic analysis |
5RTM |
Metagenomics and metabolomic analysis
Type:
CRO / CMO
|
|
ADM BIOPOLIS |
CRO / CMO
Screening |
Preclinical validation platforms: C.elegans model for functional food, ingredients and drug trials |
5RTM |
Preclinical validation platforms: C.elegans model for functional food, ingredients and drug trials
Type:
CRO / CMO
Screening
|
|
ADM BIOPOLIS |
CRO / CMO
Screening |
Novel functional probiotics screening, validation and production |
1R+D |
Novel functional probiotics screening, validation and production
Type:
CRO / CMO
Screening
|
|
ADM BIOPOLIS |
CRO / CMO |
Recombinant protein expression systems |
1R+D |
Recombinant protein expression systems
Type:
CRO / CMO
|
 |
APTUS Biotech |
Drug Delivery
Enabling Technologies
Screening |
AptusBiotech has built an aptamer development platform, from cell lines to protein, peptides or small molecule selections procedures, providing high quality candidates for pre-clinical trials with an innovative drug development process based on aptamers |
1R+D |
AptusBiotech has built an aptamer development platform, from cell lines to protein, peptides or small molecule selections procedures, providing high quality candidates for pre-clinical trials with an innovative drug development process based on aptamers
Type:
Drug Delivery
Enabling Technologies
Screening
|
 |
Arthex Biotech |
Drug Delivery |
ENTRY Platform: Enhancing antimiR delivery to treat unmet diseases.
ARTHEx biotech launches ENTRY,a platform that will allow it to advance its pipeline of drugs by providing tissue-enriched delivery of antimiRs.
The ENTRY platform improves drug delivery |
2PreV |
ENTRY Platform: Enhancing antimiR delivery to treat unmet diseases.
ARTHEx biotech launches ENTRY,a platform that will allow it to advance its pipeline of drugs by providing tissue-enriched delivery of antimiRs.
The ENTRY platform improves drug delivery
Type:
Drug Delivery
|
 |
Biobide |
CRO / CMO
Screening |
Zebrafish Toxicity screening assays for Pharma, Biotech, Chemical, Agrochemical, Tobacco, Nutraceutical, and Cosmetic companies for candidate selection in early discovery and development phases:Developmental toxicity, Neurotoxicity, Cardiotoxicity, Hepati |
5RTM |
Zebrafish Toxicity screening assays for Pharma, Biotech, Chemical, Agrochemical, Tobacco, Nutraceutical, and Cosmetic companies for candidate selection in early discovery and development phases:Developmental toxicity, Neurotoxicity, Cardiotoxicity, Hepati
Type:
CRO / CMO
Screening
|
|
Biobide |
CRO / CMO |
Zebrafish Lines Management:In parallel to the increase in the use of zebrafish as an animal model, Biobide has developed a Zebrafish Sperm Cryopreservation and In vitro fertilization protocol to answer the need to implement a program to reduce the number |
5RTM |
Zebrafish Lines Management:In parallel to the increase in the use of zebrafish as an animal model, Biobide has developed a Zebrafish Sperm Cryopreservation and In vitro fertilization protocol to answer the need to implement a program to reduce the number
Type:
CRO / CMO
|
|
Biobide |
CRO / CMO
Screening |
Zebrafish Efficacy Assays for different therapeutic areas in drug discovery: Neurodegenerative diseases, Oncology, Cardiovascular, Immune diseases, Infectious diseases, Rare diseases (DMD, ALS...), other models, etc. |
5RTM |
Zebrafish Efficacy Assays for different therapeutic areas in drug discovery: Neurodegenerative diseases, Oncology, Cardiovascular, Immune diseases, Infectious diseases, Rare diseases (DMD, ALS...), other models, etc.
Type:
CRO / CMO
Screening
|
|
Biobide |
CRO / CMO
Screening |
Zebrafish Disease Model Generation and Target Identification and Validation for different therapeutic areas through morpholinos, transgenesis (Tol2 Kit), CRISPR/Cas9, TALENS, chemically induced models, xenograft models, etc. |
5RTM |
Zebrafish Disease Model Generation and Target Identification and Validation for different therapeutic areas through morpholinos, transgenesis (Tol2 Kit), CRISPR/Cas9, TALENS, chemically induced models, xenograft models, etc.
Type:
CRO / CMO
Screening
|
 |
BIONET INGENIERÍA |
Enabling Technologies |
Smart functional modules to be coupled to bioreactor technologies in a Plug&Play fashion. Examples of these are the Continuous Process Modules for performance of continuous processing, and the bBreath module for the analysis of gas composition at the exha |
5RTM |
Smart functional modules to be coupled to bioreactor technologies in a Plug&Play fashion. Examples of these are the Continuous Process Modules for performance of continuous processing, and the bBreath module for the analysis of gas composition at the exha
Type:
Enabling Technologies
|
|
BIONET INGENIERÍA |
CRO / CMO
Enabling Technologies
Screening |
Rocking bioreactor with patentend 2D movement (Cell-tainer Biosolutions GmbH) for microbial and cell culture applications. Lab and Pilot scale. |
5RTM |
Rocking bioreactor with patentend 2D movement (Cell-tainer Biosolutions GmbH) for microbial and cell culture applications. Lab and Pilot scale.
Type:
CRO / CMO
Enabling Technologies
Screening
|
|
BIONET INGENIERÍA |
CRO / CMO
Enabling Technologies
Screening |
Glass labscale bioreactors |
5RTM |
Glass labscale bioreactors
Type:
CRO / CMO
Enabling Technologies
Screening
|
|
BIONET INGENIERÍA |
Enabling Technologies
Screening |
Labscale Tangential Flow Filtration units, very flexible for R&D since it allows the integration of all types of membranes: ceramic, hollow fiber and cassettes |
5RTM |
Labscale Tangential Flow Filtration units, very flexible for R&D since it allows the integration of all types of membranes: ceramic, hollow fiber and cassettes
Type:
Enabling Technologies
Screening
|
 |
CIBER |
Enabling Technologies
Others |
High Performance Computing. Integrated Infrastructure on Production and characterization of Nanomaterials, Biomaterials and systems in Biomedicine |
1R+D |
High Performance Computing. Integrated Infrastructure on Production and characterization of Nanomaterials, Biomaterials and systems in Biomedicine
Type:
Enabling Technologies
Others
|
|
CIBER |
Others |
NewroPharma: A Target Validation Platform, provide a comprehensive list of preclinical drug development services to pharmaceutical partners. |
2PreV |
NewroPharma: A Target Validation Platform, provide a comprehensive list of preclinical drug development services to pharmaceutical partners.
Type:
Others
|
|
CIBER |
CRO / CMO
Enabling Technologies
Screening |
Preclinical Validation-Bioimaging. Integrated Infrastructure on Production and characterization of Nanomaterials, Biomaterials and systems in Biomedicine |
2PreV |
Preclinical Validation-Bioimaging. Integrated Infrastructure on Production and characterization of Nanomaterials, Biomaterials and systems in Biomedicine
Type:
CRO / CMO
Enabling Technologies
Screening
|
|
CIBER |
Others |
Bilateral Pupillometry Platform for small Animals |
2PreV |
Bilateral Pupillometry Platform for small Animals
Type:
Others
|
|
CIBER |
CRO / CMO
Enabling Technologies |
Preclinical Validation-Tissue, Biomaterial and Surface Characterization |
2PreV |
Preclinical Validation-Tissue, Biomaterial and Surface Characterization
Type:
CRO / CMO
Enabling Technologies
|
|
CIBER |
CRO / CMO
Enabling Technologies
Others |
Production of Customized Biomaterials, Nanomaterials & Nanoconjugates |
5RTM |
Production of Customized Biomaterials, Nanomaterials & Nanoconjugates
Type:
CRO / CMO
Enabling Technologies
Others
|
|
CIBER |
CRO / CMO
Enabling Technologies
Others |
Production of Customized Biomolecules (Antibodies, Proteins and Peptides) |
5RTM |
Production of Customized Biomolecules (Antibodies, Proteins and Peptides)
Type:
CRO / CMO
Enabling Technologies
Others
|
 |
Enzymlogic |
CRO / CMO
Screening |
KINETICfinder® is a high throughput kinetic platform that delivers all key binding kinetics (kon, koff, residence time) and affinity (Kd) parameters for reversible binders quickly and at scale. |
5RTM |
KINETICfinder® is a high throughput kinetic platform that delivers all key binding kinetics (kon, koff, residence time) and affinity (Kd) parameters for reversible binders quickly and at scale.
Type:
CRO / CMO
Screening
|
|
Enzymlogic |
CRO / CMO
Screening |
COVALfinder® is a robust kinetic platform that delivers all key inactivation (kinact, kinact/KI, T1/2∞) and affinity (KI) parameters for irreversible binders. |
5RTM |
COVALfinder® is a robust kinetic platform that delivers all key inactivation (kinact, kinact/KI, T1/2∞) and affinity (KI) parameters for irreversible binders.
Type:
CRO / CMO
Screening
|
 |
FUND. PROGRESO Y SALUD |
Enabling Technologies |
Hybridome/Antibody Production Platform |
1R+D |
Hybridome/Antibody Production Platform
Type:
Enabling Technologies
|
|
FUND. PROGRESO Y SALUD |
CRO / CMO |
Maturing technological platform in advanced therapies: setting up and monitoring of clinical trials |
3CV |
Maturing technological platform in advanced therapies: setting up and monitoring of clinical trials
Type:
CRO / CMO
|
|
FUND. PROGRESO Y SALUD |
Drug Delivery |
Liposome delivery System (Prostate Cancer) |
1R+D |
Liposome delivery System (Prostate Cancer)
Type:
Drug Delivery
|
|
FUND. PROGRESO Y SALUD |
Screening |
Screening Cell lines & Animal Models |
1R+D |
Screening Cell lines & Animal Models
Type:
Screening
|
|
FUND. PROGRESO Y SALUD |
CRO / CMO |
Andalusian's genomics and bioinformatic platform / Nanoimaging & Metabolomic platform / Biobank |
5RTM |
Andalusian's genomics and bioinformatic platform / Nanoimaging & Metabolomic platform / Biobank
Type:
CRO / CMO
|
 |
Fundacion MEDINA |
CRO / CMO |
Chemical Isolation & Structural Elucidation of natural products |
3CV |
Chemical Isolation & Structural Elucidation of natural products
Type:
CRO / CMO
|
|
Fundacion MEDINA |
Enabling Technologies
Screening |
Mass spectrometry metabolomics |
1R+D |
Mass spectrometry metabolomics
Type:
Enabling Technologies
Screening
|
|
Fundacion MEDINA |
CRO / CMO |
Microbial and Mammalian cell culturing |
3CV |
Microbial and Mammalian cell culturing
Type:
CRO / CMO
|
|
Fundacion MEDINA |
Screening |
High throughput imaging platform for phenotypic drug discovery |
2PreV |
High throughput imaging platform for phenotypic drug discovery
Type:
Screening
|
|
Fundacion MEDINA |
Screening |
Microbial Natural Product Libraries |
3CV |
Microbial Natural Product Libraries
Type:
Screening
|
|
Fundacion MEDINA |
CRO / CMO |
Preclinical Safety Platform |
3CV |
Preclinical Safety Platform
Type:
CRO / CMO
|
|
Fundacion MEDINA |
CRO / CMO |
Bioanalytical Platform |
3CV |
Bioanalytical Platform
Type:
CRO / CMO
|
|
Fundacion MEDINA |
Screening |
High throughput screening platform for drug discovery |
3CV |
High throughput screening platform for drug discovery
Type:
Screening
|
 |
Histocell |
CRO / CMO |
GMP Cell Bank Therapy Manufacturing (MCB, WCB) |
5RTM |
GMP Cell Bank Therapy Manufacturing (MCB, WCB)
Type:
CRO / CMO
|
|
Histocell |
CRO / CMO |
GMP Cell Therapy Manufacturing (DS & DP) |
5RTM |
GMP Cell Therapy Manufacturing (DS & DP)
Type:
CRO / CMO
|
|
Histocell |
CRO / CMO |
GMP Biological Product Manufacturing from Human Cells (DS & DP) |
5RTM |
GMP Biological Product Manufacturing from Human Cells (DS & DP)
Type:
CRO / CMO
|
 |
IIS La Fe |
Enabling Technologies
Screening |
Biotechnology platform: Expression and purification of recombinant proteins. Fragment-based screening |
1R+D |
Biotechnology platform: Expression and purification of recombinant proteins. Fragment-based screening
Type:
Enabling Technologies
Screening
|
|
IIS La Fe |
Screening |
Analytical Unit certified GLP: Targeted and untargeted metabolic studies by combination of chromatography and mass spectrometry techniques |
3CV |
Analytical Unit certified GLP: Targeted and untargeted metabolic studies by combination of chromatography and mass spectrometry techniques
Type:
Screening
|
|
IIS La Fe |
CRO / CMO
Drug Delivery |
Advanced Therapies Unit: offers services that require specially designed infrastructures under the most demanding regulatory framework for the development of pre-clinical and clinical studies within the Advanced Therapies programs. |
5RTM |
Advanced Therapies Unit: offers services that require specially designed infrastructures under the most demanding regulatory framework for the development of pre-clinical and clinical studies within the Advanced Therapies programs.
Type:
CRO / CMO
Drug Delivery
|
|
IIS La Fe |
Enabling Technologies |
Experimental Radiology and Imaging Biomarkers Platform: MR imaging acquisition, image acquisition US, angiographic studies and processing by large and small animal imaging (3 Tesla Magnetic Resonance Unit,etc.) |
1R+D |
Experimental Radiology and Imaging Biomarkers Platform: MR imaging acquisition, image acquisition US, angiographic studies and processing by large and small animal imaging (3 Tesla Magnetic Resonance Unit,etc.)
Type:
Enabling Technologies
|
|
IIS La Fe |
Screening |
Epigenomics Unit: DNA methylation and histone modifications at a genomic scale. High-performance technologies based on arrays of methylation and chromatin immunoprecipitation (ChIP) analysis. Any kind of samples (FFPE and frozen tumour). |
2PreV |
Epigenomics Unit: DNA methylation and histone modifications at a genomic scale. High-performance technologies based on arrays of methylation and chromatin immunoprecipitation (ChIP) analysis. Any kind of samples (FFPE and frozen tumour).
Type:
Screening
|
|
IIS La Fe |
Enabling Technologies |
Platform for Health ICT: Big Data and Digital Health.Treatment of large amounts of data (RWD) and development of methodologies and tools to support clinical decisions |
2PreV |
Platform for Health ICT: Big Data and Digital Health.Treatment of large amounts of data (RWD) and development of methodologies and tools to support clinical decisions
Type:
Enabling Technologies
|
|
IIS La Fe |
CRO / CMO |
Clinical and Products with Biological Activity Research Unit (UICAB): Participates in the development of clinical studies aimed at different pathologies, providing healthcare support in highly complex studies, such as Clinical Trials in early phases |
5RTM |
Clinical and Products with Biological Activity Research Unit (UICAB): Participates in the development of clinical studies aimed at different pathologies, providing healthcare support in highly complex studies, such as Clinical Trials in early phases
Type:
CRO / CMO
|
|
IIS La Fe |
Enabling Technologies |
Data Science, Biostatistics and Bioinformatics Unit: unsupervised analysis (clustering, PCA, SOM), analysis of omic data, simulation techniques (Monte Carlo) and resampling (Bootstrapping), R Programming, etc. |
1R+D |
Data Science, Biostatistics and Bioinformatics Unit: unsupervised analysis (clustering, PCA, SOM), analysis of omic data, simulation techniques (Monte Carlo) and resampling (Bootstrapping), R Programming, etc.
Type:
Enabling Technologies
|
|
IIS La Fe |
Screening |
Cytomics Unit: FACSAria-III cell sorter, FACSCanto-II flow cytometer and two high-content screening systems (Scan^R, Olympus, and InCell Analyzer, GE) |
1R+D |
Cytomics Unit: FACSAria-III cell sorter, FACSCanto-II flow cytometer and two high-content screening systems (Scan^R, Olympus, and InCell Analyzer, GE)
Type:
Screening
|
|
IIS La Fe |
|
Biolectronics, Signal Processing and Algorithmy Unit: provides support in the development of medical devices related to advanced signal processing, for the optimization of diagnostics and therapeutic applications. |
1R+D |
Biolectronics, Signal Processing and Algorithmy Unit: provides support in the development of medical devices related to advanced signal processing, for the optimization of diagnostics and therapeutic applications.
Type:
|
|
IIS La Fe |
Screening |
Genomic Unit: Next Generation Sequencing by Nexseq500 (Illumina), Ion PGM and Ion Proton. Arrays services by Affymetrix Platform |
1R+D |
Genomic Unit: Next Generation Sequencing by Nexseq500 (Illumina), Ion PGM and Ion Proton. Arrays services by Affymetrix Platform
Type:
Screening
|
 |
IMMUNOSTEP |
Enabling Technologies |
Reagents, columns and devices for Cell separation in Blood and Lymphatic systems |
2PreV |
Reagents, columns and devices for Cell separation in Blood and Lymphatic systems
Type:
Enabling Technologies
|
|
IMMUNOSTEP |
Enabling Technologies |
This kit is intended for RUO in the purification and identification of human exosomes from Cell Culture, Blood and Urine samples, For flow cytometric detection. |
5RTM |
This kit is intended for RUO in the purification and identification of human exosomes from Cell Culture, Blood and Urine samples, For flow cytometric detection.
Type:
Enabling Technologies
|
 |
InnoUp Farma |
Others |
Oral nanoparticles-based platform with the capacity to modulate the immune response and to increase drug bioavailability |
3CV |
Oral nanoparticles-based platform with the capacity to modulate the immune response and to increase drug bioavailability
Type:
Others
|
 |
Institut Quimic de Sarrià (IQS) |
CRO / CMO
Drug Delivery
Enabling Technologies |
Peptides. Design, optimization and production of peptides and conjugates. |
1R+D |
Peptides. Design, optimization and production of peptides and conjugates.
Type:
CRO / CMO
Drug Delivery
Enabling Technologies
|
|
Institut Quimic de Sarrià (IQS) |
CRO / CMO
Drug Delivery
Enabling Technologies
Others |
Biomaterials and Nanomaterials. Development of nanomaterials and nanoparticles. Biopolymers and lipidic vesicles. |
5RTM |
Biomaterials and Nanomaterials. Development of nanomaterials and nanoparticles. Biopolymers and lipidic vesicles.
Type:
CRO / CMO
Drug Delivery
Enabling Technologies
Others
|
|
Institut Quimic de Sarrià (IQS) |
CRO / CMO |
Animal cell bioprocess. Production of biomolecules. Process development & optimization. Bioreactors. |
5RTM |
Animal cell bioprocess. Production of biomolecules. Process development & optimization. Bioreactors.
Type:
CRO / CMO
|
|
Institut Quimic de Sarrià (IQS) |
CRO / CMO
Screening |
Analytics. GMP Analytical services: Development and routine analysis of bioproducts. |
1R+D |
Analytics. GMP Analytical services: Development and routine analysis of bioproducts.
Type:
CRO / CMO
Screening
|
 |
IRYCIS |
Others
Screening |
miRNA platform to collaborate in the development and commercialization of new biomarkers for diagnosis, prognosis and drug response |
3CV |
miRNA platform to collaborate in the development and commercialization of new biomarkers for diagnosis, prognosis and drug response
Type:
Others
Screening
|
 |
Laminar Pharma |
Enabling Technologies |
Membrane-Lipid Therapy (MLT), a novel therapeutic approach targeting lipid metabolism |
3CV |
Membrane-Lipid Therapy (MLT), a novel therapeutic approach targeting lipid metabolism
Type:
Enabling Technologies
|
 |
Leitat |
CRO / CMO
Enabling Technologies
Screening |
In vivo animal model platform (Oncology, Angiogenesis, Efficacy, pre-Tox, Biodistribution, pre-Pk, Drug Reprofiling, humanised pseudogerm-free murine models)
Syngenic & xenogenic, Subcutaneous & orthotopic, Experimental & spontaneous metastasis, Patient |
5RTM |
In vivo animal model platform (Oncology, Angiogenesis, Efficacy, pre-Tox, Biodistribution, pre-Pk, Drug Reprofiling, humanised pseudogerm-free murine models)
Syngenic & xenogenic, Subcutaneous & orthotopic, Experimental & spontaneous metastasis, Patient
Type:
CRO / CMO
Enabling Technologies
Screening
|
|
Leitat |
CRO / CMO
Drug Delivery
Enabling Technologies
Screening |
In vitro cellular models platform (Efficacy, pre-Tox, Mechanism of Action, Drug Reprofiling).
Studies of proliferation, viability, apoptosis, migration, invasion, wound healing, adhesion, and many others in monolayer cell cultures of primary cells. |
5RTM |
In vitro cellular models platform (Efficacy, pre-Tox, Mechanism of Action, Drug Reprofiling).
Studies of proliferation, viability, apoptosis, migration, invasion, wound healing, adhesion, and many others in monolayer cell cultures of primary cells.
Type:
CRO / CMO
Drug Delivery
Enabling Technologies
Screening
|
|
Leitat |
CRO / CMO
Drug Delivery
Enabling Technologies
Screening |
Polyclonal & Monoclonal Antibody Generation and Production Platform.
Recombinant proteins, Immunization, Serum title, Mouse polyclonals, Fusion, Screening, Cloning, Hybridomas, Isotyping, Production & Purification, F(ab)2, scFv, Conjugation, ELISA |
5RTM |
Polyclonal & Monoclonal Antibody Generation and Production Platform.
Recombinant proteins, Immunization, Serum title, Mouse polyclonals, Fusion, Screening, Cloning, Hybridomas, Isotyping, Production & Purification, F(ab)2, scFv, Conjugation, ELISA
Type:
CRO / CMO
Drug Delivery
Enabling Technologies
Screening
|
 |
Microomics Systems |
CRO / CMO
Enabling Technologies
Screening |
High quality metagenomics, genomics and transcriptomics services to companies industrial research centers in the fields of: pre and probiotics, metabolic studies, human and animal health, dental treatments and agriculture solutions (biofertilizers) |
5RTM |
High quality metagenomics, genomics and transcriptomics services to companies industrial research centers in the fields of: pre and probiotics, metabolic studies, human and animal health, dental treatments and agriculture solutions (biofertilizers)
Type:
CRO / CMO
Enabling Technologies
Screening
|
 |
NEURAL THERAPIES |
CRO / CMO |
Screening of molecules as neuroprotectors, mainly in cerebrovascular and Alzheimer diseases. Evaluation on infarct volume, behavioral responses, inflammation, homeostatic response and cell death.
Models: Focal ischemia, global ischemia, oxygen and OGD. |
1R+D |
Screening of molecules as neuroprotectors, mainly in cerebrovascular and Alzheimer diseases. Evaluation on infarct volume, behavioral responses, inflammation, homeostatic response and cell death.
Models: Focal ischemia, global ischemia, oxygen and OGD.
Type:
CRO / CMO
|
 |
OPERON |
Screening |
Opegen S.pneumoniae: Molecular test for the genotyping of Streptococcus pneumoniae infections |
5RTM |
Opegen S.pneumoniae: Molecular test for the genotyping of Streptococcus pneumoniae infections
Type:
Screening
|
 |
PROMEGA BIOTECH IBÉRICA |
Enabling Technologies |
Maxprep Liquid Handler, robotic Nucleic Acid Purification System |
5RTM |
Maxprep Liquid Handler, robotic Nucleic Acid Purification System
Type:
Enabling Technologies
|
|
PROMEGA BIOTECH IBÉRICA |
Enabling Technologies
Screening |
GloMax Discover Microplate Reader. Multimode Plate Reader for luminescence, fluorescence and absorbance measurements |
5RTM |
GloMax Discover Microplate Reader. Multimode Plate Reader for luminescence, fluorescence and absorbance measurements
Type:
Enabling Technologies
Screening
|
|
PROMEGA BIOTECH IBÉRICA |
CRO / CMO
Enabling Technologies |
Custom Manufacturing. We apply our knowledge and experience in technology development, manufacturing and quality systems with a cross-functional team of peers to comply with international quality standards (ISO) and produce custom products that will be ma |
5RTM |
Custom Manufacturing. We apply our knowledge and experience in technology development, manufacturing and quality systems with a cross-functional team of peers to comply with international quality standards (ISO) and produce custom products that will be ma
Type:
CRO / CMO
Enabling Technologies
|
 |
Sylentis |
Others |
SIRFINDER(TM). RNA interference prediction software based on artificial intelligence (AI) to design the best candidates for a specific target and to predict inhibition efficiency with improved specificity and sensitivity. |
5RTM |
SIRFINDER(TM). RNA interference prediction software based on artificial intelligence (AI) to design the best candidates for a specific target and to predict inhibition efficiency with improved specificity and sensitivity.
Type:
Others
|
 |
VIVEBIOTECH |
CRO / CMO |
Development of more cost-effective gene therapy processes |
3CV |
Development of more cost-effective gene therapy processes
Type:
CRO / CMO
|
|
VIVEBIOTECH |
CRO / CMO |
LENTISOMA platform: for the R&D manufacture of lentiviral vectors with an enhanced safety profile. |
3CV |
LENTISOMA platform: for the R&D manufacture of lentiviral vectors with an enhanced safety profile.
Type:
CRO / CMO
|
 |
Vivia Biotech |
CRO / CMO
Enabling Technologies
Screening |
Cytometry Analysis for Personalized Medicine/Diagnosis/Pharma Profiling. Drug profiling and biomarker discovery collaborations |
5RTM |
Cytometry Analysis for Personalized Medicine/Diagnosis/Pharma Profiling. Drug profiling and biomarker discovery collaborations
Type:
CRO / CMO
Enabling Technologies
Screening
|
 |
ZeClinics |
CRO / CMO
Screening |
Discovery-preclinical safety services for drug discovery using zebrafish. ZeTox: acute, chronic, general and organ-specific toxicology tests, endocrine disruption assays, reproductive toxicology |
5RTM |
Discovery-preclinical safety services for drug discovery using zebrafish. ZeTox: acute, chronic, general and organ-specific toxicology tests, endocrine disruption assays, reproductive toxicology
Type:
CRO / CMO
Screening
|
|
ZeClinics |
CRO / CMO
Enabling Technologies
Screening |
Discovery-preclinical disease modeling services using zebrafish. ZeGenesis: generation of knock-out, knock-in, transgenics zebrafish or cell lines through CRISPR/Cas9. |
5RTM |
Discovery-preclinical disease modeling services using zebrafish. ZeGenesis: generation of knock-out, knock-in, transgenics zebrafish or cell lines through CRISPR/Cas9.
Type:
CRO / CMO
Enabling Technologies
Screening
|
|
ZeClinics |
CRO / CMO
Enabling Technologies
Screening |
Discovery-preclinical services for drug efficacy using zebrafish. ZeEfficacy: early bioactivity evaluation of compound libraries with high-content phenotypical screenings. |
5RTM |
Discovery-preclinical services for drug efficacy using zebrafish. ZeEfficacy: early bioactivity evaluation of compound libraries with high-content phenotypical screenings.
Type:
CRO / CMO
Enabling Technologies
Screening
|